Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy
This page documents how this source is reused across Claim by Claim. A source can support, challenge, qualify or contextualize different claims; appearing here does not imply endorsement of every linked proposition.
Evidence roles describe what this source helps establish inside each Investigation. They are local to that use, not permanent labels attached to the publication itself.
Three 2025–2026 same-clinic retrospective observational publications report survival correlations with urinary pH in selected cancer cohorts, including 203 NSCLC and 129 colorectal patients. Likely overlapping clinic/date cohorts, other anticancer care, nonrandom selection and no blood or tumor-pH demonstration prevent an inference that diet alkalizes blood or treats cancer.